Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Comprehensible, personal, up-to-date and rapid: E-mail service of the Cancer Information Service gets good grades from users in a survey

No. 59 | 07/11/2011 | by Koh

Have we been able to help you with your inquiry at the Cancer Information Service? The e-mail service of the Cancer Information Service (Krebsinformationsdienst, KID) has questioned its users about this. The survey produced a positive result: Almost all of those questioned found the responses provided by the Cancer Information Service easy to understand and helpful in their situation. Ninety-six percent are very satisfied or satisfied with the performance of the e-mail service. Participants in the survey particularly appreciated that the Cancer Information Service provides personal responses to every inquiry.

© dkfz.de

For ten years now, the Cancer Information Service (Krebsinformationsdienst, KID) at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) has also answered inquiries received by e-mail. This service is well accepted by users. In 2010 alone, the e-mail team individually answered about 5,000 inquiries. However, does the information sent by the Cancer Information Service via e-mail meet the expectations and needs of users? “Our colleagues of the telephone service can simply ask to find out whether a caller is satisfied with the answer provided. In the e-mail service, it is more difficult to determine user satisfaction,” says Ursula Will, who is head of the e-mail service at the Cancer Information Service.

To get a clear picture, the Cancer Information Service has recently conducted a representative survey among users of the e-mail service. In total, 554 survey participants completed the questionnaire. Its evaluation has now confirmed that users of the service are very satisfied. For the most part (76 percent), responses arrived within no more than one or two workdays after the inquiry had been made. Practically all survey participants (99.6 percent) found the responses comprehensible and claimed that the information provided was helpful in their situation (98 percent). Ninety percent of respondents considered the amount and extent of information provided by the service in its e-mail responses as just right. All in all, 96 percent of those questioned are very satisfied or satisfied with the performance of the e-mail service.

Users – of which, like those of the telephone service, two thirds are women – predominantly (75 percent) come across the offering of the e-mail service on the Internet pages of the Cancer Information Service. Seventy-two percent of them particularly appreciate the fact that the service responds to their personal requests instead of just providing standard texts. Sixty percent of the respondents emphasize the professional competence of their correspondence partners, 46 percent commend the scientifically profound information provided, and another 43 percent commend its up-to-dateness.

“The survey confirms that our way of responding to e-mail inquiries meets the needs of users,” said Ursula Will. Almost half of those questioned state that after receiving the e-mail response they have a better knowledge of the options available in their particular case. About 40 percent of the respondents use the information provided by the Cancer Information Service as a basis for conversations with their doctors. “Patients today want to be in the know and have a say in all decisions,” says Will, who is a doctor herself. “The complexity of the inquiries we receive very clearly shows that people have gathered a lot of knowledge beforehand.” For the e-mail team staff, almost every inquiry therefore means intensive research into the matter. “We have hardly any questions now that are easy to answer,” says Ursula Will.

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS